Roni T. Falk
About
Roni T. Falk is a scholar working on Oncology, Genetics and Cancer Research.
According to data from OpenAlex, Roni T. Falk has authored 132 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 53 papers in Genetics and 28 papers in Cancer Research. Recurrent topics in Roni T. Falk's work include Cancer Risks and Factors (47 papers), Estrogen and related hormone effects (45 papers) and Breast Cancer Treatment Studies (12 papers). Roni T. Falk is often cited by papers focused on Cancer Risks and Factors (47 papers), Estrogen and related hormone effects (45 papers) and Breast Cancer Treatment Studies (12 papers). Roni T. Falk collaborates with scholars based in United States, United Kingdom and Canada. Roni T. Falk's co-authors include William D. Travis, Xia Xu, Louise A. Brinton, Regina G. Ziegler, Timothy D. Veenstra, Walter L. Rush, Anthony A. Gal, Michael N. Koss, Douglas B. Flieder and Marian V. Fleming and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.
In The Last Decade
Roni T. Falk
131 papers receiving 5.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Roni T. Falk United States | 39 | 2.4k | 1.3k | 1.2k | 1.1k | 840 | 132 | 5.4k | ||
| Per Lenner Sweden | 46 | 2.5k 1.0× | 1.2k 0.9× | 1.8k 1.5× | 894 0.8× | 566 0.7× | 149 | 6.6k | ||
| Kathleen M. Egan United States | 49 | 2.8k 1.1× | 645 0.5× | 1.6k 1.4× | 1.1k 1.0× | 1.0k 1.2× | 159 | 7.8k | ||
| Wen‐Yi Huang United States | 46 | 1.6k 0.6× | 553 0.4× | 2.0k 1.7× | 823 0.7× | 816 1.0× | 173 | 6.1k | ||
| B. E. Henderson United States | 36 | 1.6k 0.7× | 578 0.5× | 819 0.7× | 1.3k 1.2× | 641 0.8× | 52 | 4.9k | ||
| Keun‐Young Yoo South Korea | 41 | 1.4k 0.6× | 576 0.5× | 1.0k 0.9× | 652 0.6× | 728 0.9× | 127 | 4.2k | ||
| Ulrich R. Fölsch Germany | 49 | 2.2k 0.9× | 1.1k 0.9× | 2.6k 2.3× | 714 0.6× | 931 1.1× | 207 | 7.6k | ||
| Seiichiro Yamamoto Japan | 31 | 1.8k 0.7× | 988 0.8× | 1.2k 1.0× | 350 0.3× | 620 0.7× | 60 | 4.0k | ||
| Anthony A. Fryer United Kingdom | 56 | 2.0k 0.8× | 1.7k 1.3× | 5.4k 4.6× | 1.2k 1.1× | 735 0.9× | 245 | 11.2k | ||
| Ivan Brandslund Denmark | 40 | 925 0.4× | 519 0.4× | 1.5k 1.3× | 620 0.6× | 532 0.6× | 277 | 5.6k | ||
| Anne Zeleniuch‐Jacquotte United States | 52 | 3.3k 1.4× | 485 0.4× | 2.1k 1.8× | 1.9k 1.7× | 609 0.7× | 168 | 8.9k |
Countries citing papers authored by Roni T. Falk
Since
Specialization
Citations
This map shows the geographic impact of Roni T. Falk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roni T. Falk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roni T. Falk more than expected).
Fields of papers citing papers by Roni T. Falk
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Roni T. Falk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roni T. Falk. The network helps show where Roni T. Falk may publish in the future.
Co-authorship network of co-authors of Roni T. Falk
This figure shows the co-authorship network connecting the top 25 collaborators of Roni T. Falk. A scholar is included among the top collaborators of Roni T. Falk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roni T. Falk. Roni T. Falk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ward, Mary H., Jessica M. Madrigal, Rena R. Jones, et al.. (2023). Glyphosate in house dust and risk of childhood acute lymphoblastic leukemia in California. Environment International. 172. 107777–107777.
2.
Loftfield, Erikka, Roni T. Falk, Joshua N. Sampson, et al.. (2022). Prospective Associations of Circulating Bile Acids and Short-Chain Fatty Acids With Incident Colorectal Cancer. JNCI Cancer Spectrum. 6(3).
3.
Phuong, L., Austin Miller, Amanda Black, et al.. (2022). Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study. American Journal of Obstetrics and Gynecology. 227(1). 61.e1–61.e18.
4.
Figueroa, Jonine D., Gretchen L. Gierach, Máire A. Duggan, et al.. (2021). Risk factors for breast cancer development by tumor characteristics among women with benign breast disease. Breast Cancer Research. 23(1). 34–34.
5.
Michels, Kara A., Doug C. Bauer, Louise A. Brinton, et al.. (2021). Endogenous Progestogens and Colorectal Cancer Risk among Postmenopausal Women. Cancer Epidemiology Biomarkers & Prevention. 30(6). 1100–1105.
6.
Oh, Hannah, Shaoqi Fan, Roni T. Falk, et al.. (2020). Relationship of Serum Progesterone and Progesterone Metabolites with Mammographic Breast Density and Terminal Ductal Lobular Unit Involution among Women Undergoing Diagnostic Breast Biopsy. Journal of Clinical Medicine. 9(1). 245–245.
7.
Wang, Shaoming, Ruth M. Pfeiffer, Gretchen L. Gierach, & Roni T. Falk. (2020). Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort. Breast Cancer Research. 22(1). 129–129.
8.
Trabert, Britton, Kara A. Michels, Garnet L. Anderson, et al.. (2019). Circulating androgens and postmenopausal ovarian cancer risk in the Women's Health Initiative Observational Study. International Journal of Cancer. 145(8). 2051–2060.
9.
Petrick, Jessica L., Roni T. Falk, Paula L. Hyland, et al.. (2018). Association between circulating levels of sex steroid hormones and esophageal adenocarcinoma in the FINBAR Study. PLoS ONE. 13(1). e0190325–e0190325.
10.
Falk, Roni T., JoAnn E. Manson, Vanessa M. Barnabei, et al.. (2018). Estrogen metabolism in menopausal hormone users in the women's health initiative observational study: Does it differ between estrogen plus progestin and estrogen alone?. International Journal of Cancer. 144(4). 730–740.
11.
Cook, Michael B., Frank Z. Stanczyk, Shannon N. Wood, et al.. (2017). Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations. Cancer Epidemiology Biomarkers & Prevention. 26(11). 1660–1666.
12.
Brinton, Louise A., Britton Trabert, Garnet L. Anderson, et al.. (2016). Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women. Cancer Epidemiology Biomarkers & Prevention. 25(7). 1081–1089.
13.
Sampson, Joshua N., Roni T. Falk, Catherine Schairer, et al.. (2016). Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women. Cancer Research. 77(4). 918–925.
14.
Falk, Roni T., Annetine Staff, Gary Bradwin, S. Ananth Karumanchi, & Rebecca Troisi. (2016). A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Causes & Control. 27(8). 1009–1017.
15.
Trabert, Britton, Roni T. Falk, Frank Z. Stanczyk, et al.. (2015). Reproducibility of an assay to measure serum progesterone metabolites that may be related to breast cancer risk using liquid chromatography-tandem mass spectrometry. Hormone Molecular Biology and Clinical Investigation. 23(3). 79–84.
16.
Black, Amanda, Paul F. Pinsky, Robert L. Grubb, et al.. (2014). Sex Steroid Hormone Metabolism in Relation to Risk of Aggressive Prostate Cancer. Cancer Epidemiology Biomarkers & Prevention. 23(11). 2374–2382.
17.
Khodr, Zeina G., Mark E. Sherman, Ruth M. Pfeiffer, et al.. (2014). Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast. Cancer Epidemiology Biomarkers & Prevention. 23(12). 2765–2773.
18.
Yang, Xiaohong R., Jonine D. Figueroa, Roni T. Falk, et al.. (2012). Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers. Breast Cancer Research. 14(2). R64–R64.
19.
Roman, John M., Regina G. Ziegler, Timothy D. Veenstra, et al.. (2005). Measuring Fifteen Simultaneously in High-Performance Spectrometry Endogenous Estrogens Human Urine by Liquid Chromatography-Mass. Analytical Chemistry. 6646–6654.
20.
DeQuattro, Vincent, et al.. (1986). Childhood familial pheochromocytoma. Conflicting results of localization techniques.. Hypertension. 8(10). 851–858.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Per Lenner Breakdown of academic impact, for papers by Kathleen M. Egan Breakdown of academic impact, for papers by Wen‐Yi Huang Breakdown of academic impact, for papers by B. E. Henderson Breakdown of academic impact, for papers by Keun‐Young Yoo Breakdown of academic impact, for papers by Ulrich R. Fölsch Breakdown of academic impact, for papers by Seiichiro Yamamoto Breakdown of academic impact, for papers by Anthony A. Fryer Breakdown of academic impact, for papers by Ivan Brandslund Breakdown of academic impact, for papers by Anne Zeleniuch‐Jacquotte